Co-Pay Vouchers May Not Be Enough To Boost Patient Adherence To Blood Thinners
Executive Summary
Acute MI patients who received voucher had 3.3% increase in persistence with clopidogrel or ticagrelor, but no significant reduction in major adverse cardiovascular events, ARTEMIS study finds.